Additional Resources for Providers

Additional Perinatal Mood Disorder Resources for Healthcare Providers

WellMama provides annual and ongoing in-service trainings for healthcare and social service professionals. The trainings help clinicians understand both basic and advanced concepts in screening, prevention, identification, and treatment of perinatal mood and anxiety disorders. WellMama can tailor individualized seminars of any length to the specific requirements of each discipline or agency. Continuing education units are provided for most healthcare professionals. Call 1-800-896-0410 for more information.

The list below of perinatal mood disorder resources can also provide information.

MedEdPPD is an excellent updated resources for clinicians, care providers, and families. They provide information and updates on current research, including screening tools and protocols. They also offer online CEU credits for providers.

Hale Publishing, company of Dr. Thomas Hale who is a leading expert on medications and breastfeeding, provides discussion forums for healthcare providers and patients on concerns related to specific medications.

Massachusetts Breastfeeding Coalition provides information on medications during breastfeeding.

Motherisk provides information on appropriate treatments for pregnant and breastfeeding mothers. The site also contains information on the safety of medications, infections, chemicals, personal products, and everyday exposures.

REPROTOX® is an information system developed by the Reproductive Toxicology Center. It contains summaries on the effects of medications, chemicals, infections, and physical agents on pregnancy, reproduction, and development.

The Infant Risk Center provides extensive information about the effect of medications on pregnancy and breastfeeding. They also have a mobile app that allows you to check a medication’s safety for lactating mothers from anywhere.

LactMed is a peer-reviewed, fully referenced database of drugs to which breastfeeding mothers may be exposed. Among the data included are maternal and infant levels of drugs, possible effects on breastfed infants and on lactation, and alternate drugs to consider.